Evidence map›Paper›PMID 25558303›Full record

ArticleAmerican health & drug benefits2014

Effects of medicare part d on disparity implications of medication therapy management eligibility criteria.

Junling Wang, Yanru Qiao, Ya-Chen Tina Shih, JoEllen Jarrett Jamison, Christina A Spivey, Liyuan Li, Jim Y Wan, Shelley I White-Means, Samuel Dagogo-Jack, William C Cushman and 1 more

Abstract read
In one paragraph

Article in American health & drug benefits, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pharmaceutical policies: effects of regulating drug insurance schemes.The Cochrane database of systematic reviews · 2022
    Pooled it
  2. Disparity Implications of Proposed 2015 Medicare Eligibility Criteria for Medication Therapy Management Services.Journal of pharmaceutical health services research : an official journal of the Royal Pharmaceutical Society of Great Britain · 2016
    Article
  3. Article
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Junling WangAssociate Professor, Department of Clinical Pharmacy, University of Tennessee College of Pharmacy, Memphis.
Yanru QiaoResearch Assistant, Department of Clinical Pharmacy, University of Tennessee College of Pharmacy, Memphis.
Ya-Chen Tina ShihAssociate Professor, Section of Hospital Medicine, Department of Medicine, and Director, Program in the Economics of Cancer, University of Chicago, IL.
JoEllen Jarrett JamisonPharmacy student, University of Tennessee Health Science Center, College of Pharmacy, Memphis.
Christina A SpiveyAssistant Professor, Department of Clinical Pharmacy, University of Tennessee College of Pharmacy, Memphis.
Liyuan LiPostdoctoral Fellow, Department of Clinical Pharmacy, University of Tennessee College of Pharmacy, Memphis.
Jim Y WanProfessor, Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis.
Shelley I White-MeansProfessor and Director, Consortium for Health Education, Economic Empowerment and Research, Department of Clinical Pharmacy, University of Tennessee College of Pharmacy, Memphis.
Samuel Dagogo-JackMullins Professor and Director, Division of Endocrinology, Diabetes and Metabolism, and Director, Clinical Research Center, University of Tennessee Health Science Center, Memphis.
William C CushmanProfessor, Departments of Preventive Medicine, Medicine, and Physiology, University of Tennessee College of Medicine, Memphis, and Chief, Preventive Medicine Section, Veterans Affairs Medical Center, Memphis, TN.
Marie Chisholm-BurnsDean and Professor, University of Tennessee College of Pharmacy, Memphis, Knoxville, and Nashville.

Funding

Reducing Racial/Ethnic Disparities in Alzheimer's-Type Dementia with MTM ServicesR01AG040146 · NIA · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI Junling None Wang · 2011 to 2026
$3.7M
NIA NIH HHS R01 AG040146
6 · The paper itself

Abstract

backgroundPrevious studies have shown that there were greater racial and ethnic disparities among individuals who were ineligible for medication therapy management (MTM) services than among MTM-eligible individuals before the implementation of Medicare Part D in 2006.

objectiveTo determine whether the implementation of Medicare Part D in 2006 correlates to changes in racial and ethnic disparities among MTM-ineligible and MTM-eligible beneficiaries.

methodsData from the Medicare Current Beneficiary Survey were analyzed in this retrospective observational analysis. To examine potential racial and ethnic disparities, non-Hispanic whites were compared with non-Hispanic blacks and Hispanics. Three aspects of disparities were analyzed, including health status, health services utilization and costs, and medication utilization patterns. A generalized difference-in-differences analysis was used to examine the changes in difference in disparities between MTM-ineligible and MTM-eligible individuals from 2004-2005 to 2007-2008 relative to changes from 2001-2002 and 2004-2005. Various multivariate regressions were used based on the types of dependent variables. A main analysis and several sensitivity analyses were conducted to represent the ranges of MTM eligibility thresholds used by Medicare Part D plans in 2010.

resultsThe main analysis showed that Part D implementation was not associated with reductions in greater racial and ethnic disparities among MTM-ineligible than MTM-eligible Medicare beneficiaries. The main analysis suggests that after Part D implementation, Medicare MTM eligibility criteria may not consistently improve the existing racial and ethnic disparities in health status, health services utilization and costs, and medication utilization. By contrast, several sensitivity analyses showed that Part D implementation did correlate with a significant reduction in greater racial disparities among the MTM-ineligible group than the MTM-eligible group in activities of daily living and in instrumental activities of daily living. Part D implementation may be also associated with a reduction in greater ethnic disparities among the MTM-ineligible group than the MTM-eligible groups in the costs of physician visits.

conclusionPart D implementation was not associated with consistent reductions in the disparity implications of the Medicare MTM eligibility criteria. The main analysis showed that Part D implementation was not associated with a reduction in disparities associated with MTM eligibility, although several sensitivity analyses did show reductions in disparities in specific aspects. Future research should explore alternative Medicare MTM eligibility criteria to eliminate racial and ethnic disparities among the Medicare population.

Identifiers

PMID25558303
PMCPMC4280526

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.